From: The prevalence and determinants of polypharmacy at age 69: a British birth cohort study
 | Gender Adjusted Relative Risk Ratios | Model One | Model Two | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
RRR | 95% LCI | 95% UCI | p | RRR | 95% LCI | 95% UCI | p | RRR | 95% LCI | 95% UCI | p | |
No Medication | (reference) | (reference) | (reference) | |||||||||
Monotherapy (1 Med) | ||||||||||||
 Gender | ||||||||||||
  Male | (reference) |  |  | 0.303 | (reference) |  |  | 0.245 | (reference) |  |  | 0.043 |
  Female | 0.9 | 0.7 | 1.1 |  | 0.9 | 0.7 | 1.1 |  | 0.8 | 0.6 | 1.0 |  |
Educational Qualifications by Age 26 | ||||||||||||
 None | (reference) |  |  | 0.008 | (reference) |  |  | 0.003 | (reference) |  |  | 0.004 |
 Vocational or O-Level Level | 0.6 | 0.5 | 0.9 |  | 0.6 | 0.4 | 0.8 |  | 0.6 | 0.4 | 0.8 |  |
 A-Level or Higher | 0.7 | 0.5 | 0.9 |  | 0.6 | 0.4 | 0.8 |  | 0.6 | 0.4 | 0.8 |  |
Social Class (age 53) | ||||||||||||
 Manual | (reference) |  |  | 0.933 | (reference) |  |  | 0.189 | (reference) |  |  | 0.116 |
 Non-Manual | 1.0 | 0.8 | 1.3 |  | 1.2 | 0.9 | 1.7 |  | 1.3 | 0.9 | 1.8 |  |
Number of Diagnosed Diseases | ||||||||||||
 None | (reference) |  |  | < 0.001 |  |  |  |  | (reference) |  |  | < 0.001 |
 One | 1.7 | 1.2 | 2.3 |  |  |  |  |  | 1.7 | 1.3 | 2.4 |  |
 Two | 1.9 | 1.3 | 2.8 |  |  |  |  |  | 2.0 | 1.4 | 3.0 |  |
 Three or More | 4.9 | 3.2 | 7.4 |  |  | 0.9 | 1.7 |  | 5.4 | 3.5 | 8.3 |  |
Disease Severity | ||||||||||||
 No Limiting Conditions | (reference) |  |  | 0.950 |  |  |  |  | (reference) |  |  | 0.090 |
 Limiting Condition | 1.0 | 0.7 | 1.4 |  |  |  |  |  | 0.8 | 0.6 | 1.0 |  |
Polypharmacy (2–4 Meds) | ||||||||||||
 Gender | ||||||||||||
  Male | (reference) |  |  | < 0.001 | (reference) |  |  | < 0.001 | (reference) |  |  | < 0.001 |
  Female | 0.7 | 0.5 | 0.8 |  | 0.6 | 0.5 | 0.8 |  | 0.5 | 0.4 | 0.6 |  |
Educational Qualifications by Age 26 | ||||||||||||
 None | (reference) |  |  | < 0.001 | (reference) |  |  |  | (reference) |  |  | < 0.001 |
 Vocational or O-Level Level | 0.7 | 0.5 | 0.9 |  | 0.7 | 0.5 | 0.9 | < 0.001 | 0.7 | 0.5 | 1.0 |  |
 A-Level or Higher | 0.5 | 0.4 | 0.7 |  | 0.5 | 0.4 | 0.7 |  | 0.5 | 0.4 | 0.7 |  |
Social Class (age 53) | ||||||||||||
 Manual | (reference) |  |  | 0.027 | (reference) |  |  | 0.880 | (reference) |  |  | 0.626 |
 Non-Manual | 0.8 | 0.6 | 1.0 |  | 1.0 | 0.8 | 1.3 |  | 1.1 | 0.8 | 1.4 |  |
Number of Diagnosed Diseases | ||||||||||||
 None | (reference) |  |  | < 0.001 |  |  |  |  | (reference) |  |  | < 0.001 |
 One | 7.4 | 5.0 | 10.8 |  |  |  |  |  | 7.2 | 4.9 | 10.6 |  |
 Two | 13.4 | 8.8 | 20.2 |  |  |  |  |  | 13.3 | 8.8 | 20.2 |  |
 Three or More | 40.2 | 25.6 | 63.2 |  |  |  |  |  | 39.5 | 24.8 | 62.3 |  |
Disease Severity | ||||||||||||
 No Limiting Conditions | (reference) |  |  | < 0.001 |  |  |  |  | (reference) |  |  | 0.923 |
 Limiting Condition | 1.8 | 1.5 | 2.3 |  |  |  |  |  | 1.0 | 0.8 | 1.3 |  |
Extreme Polypharmacy (5+ Meds) | ||||||||||||
 Gender | ||||||||||||
  Male | (reference) |  |  | < 0.001 | (reference) |  |  | < 0.001 | (reference) |  |  | < 0.001 |
  Female | 0.4 | 0.2 | 0.6 |  | 0.4 | 0.2 | 0.6 |  | 0.3 | 0.2 | 0.4 |  |
Educational Qualifications by Age 26 | ||||||||||||
 None | (reference) |  |  | < 0.001 | (reference) |  |  | < 0.001 | (reference) |  |  | < 0.001 |
 Vocational or O-Level Level | 0.4 | 0.2 | 0.6 |  | 0.4 | 0.2 | 0.7 |  | 0.4 | 0.2 | 0.8 |  |
 A-Level or Higher | 0.3 | 0.2 | 0.4 |  | 0.3 | 0.2 | 0.5 |  | 0.3 | 0.2 | 0.5 |  |
Social Class (age 53) | ||||||||||||
 Manual | (reference) |  |  | 0.001 | (reference) |  |  | 0.305 | (reference) |  |  | 0.852 |
 Non-Manual | 0.5 | 0.3 | 0.7 |  | 0.8 | 0.5 | 1.3 |  | 1.0 | 0.6 | 1.6 |  |
Number of Diagnosed Diseases | ||||||||||||
 None | (reference) |  |  | < 0.001 |  |  |  |  | (reference) |  |  | < 0.001 |
 One | 3.2 | 1.1 | 9.2 |  |  |  |  |  | 3.0 | 1.0 | 8.6 |  |
 Two | 13.6 | 5.0 | 36.6 |  |  |  |  |  | 11.8 | 4.3 | 32.2 |  |
 Three or More | 86.5 | 33.1 | 226.3 |  |  |  |  |  | 66.8 | 25.0 | 178.5 |  |
Disease Severity | ||||||||||||
 No Limiting Conditions | (reference) |  |  | < 0.001 |  |  |  |  | (reference) |  |  | 0.056 |
 Limiting Condition | 4.0 | 2.6 | 6.2 |  |  |  |  |  | 1.6 | 1.0 | 2.6 |  |